Insider Purchases: Inside the Buy
Tag: Funanc1alEdge
Insiders Bought "MicroStrategy" Shares at $90. You’re Paying $394.66. Should You?
MSTR insiders are buying, but not the stock you think. They bought STRC at $90 — while MSTR trades near $400. What gives? We break down the numbers, the Bitcoin twist, and what might be worth nibbling on.
Progress Software CEO Buys In — Maybe It’s More Than Just... Progress?
Progress Software's CEO and a director are buying shares, signaling confidence as the company posts strong earnings and raises guidance. With institutional investors owning over 121% of the float, is this under-the-radar compounder set for a rerating?
New CEO Buys In at Dave & Buster’s ($PLAY). Who Doesn’t Like a Little PLAY in Their Portfolio — or Life?
New CEO Tarun Lal takes the reins—and a big slice of $PLAY stock. With insiders buying, institutions overloaded, and sales trends improving, could this be the next comeback classic of the “entertainment” era?
Simmons Bank: Insider Buys, 116 Years of Dividends, and a Footlong Public Offering
Simmons Bank has paid dividends for over a century—and insiders just went on a buying spree. 📉 Stock’s dipped, 🔍 valuation isn’t screaming cheap, but with improving net income and institutional support, SFNC might be worth a second look. If not exciting, at least it’s… dependable?
Can Elevance Reach Higher Elevations? The CEO Thinks So
📉 After falling nearly 50% from its highs, Elevance Health just got a $2.4M vote of confidence from its CEO. Is this the cure—or just another symptom? 🏥 Dive into the numbers, the risks, and the potential rewards. And yes, there will be icons. 📊💊📈
Cogent Biosciences (COGT): The Biotech with a Plan, a Billion Cells, and a Bezuclastinib
Insiders are buying, trials are working, and Cogent just raised $230M. Meet bezuclastinib—the biotech drug with a Marvel name and real potential. 🧬💥
Will Profits From Marriott Vacations (VAC) Help You Unwind?
Insiders are buying, institutions are lounging, and dividends are flowing. Marriott Vacations Worldwide (VAC) might be your next profitable getaway — with a 3.9% yield and room to grow. But are there risks under the palm trees?
Healthpeak Properties (DOC): Insiders Are Buying—Should You?
📈 Healthpeak Properties (DOC) insiders are buying—and not just a little. But with a forward P/E north of 70 and a few post-merger integration challenges, is this stock still a hidden gem or more of a polished maybe? Dive in for the full take.
PVH: Fashion. Fundamentals. CEO Buying. Doesn't the $500M Share Buyback Scream Deep Value?
CEO Stefan Larsson just bought $1M worth of PVH stock—and he’s not alone. With iconic brands like Calvin Klein and Tommy Hilfiger, institutional support over 100%, and a massive share buyback underway, PVH may be a classic turnaround play. But is it fashionably early… or just fashionably risky?
Not Everybody Likes Hunting, But Insiders Preyed On Sportsman's Warehouse's Stock
Sportsman's Warehouse (SPWH) may be wounded, but insiders are on the prowl. With CEO and directors buying stock, and a valuation that screams “cheap,” is this outdoor retailer staging a comeback? Time to load up—or duck?